First Header Logo Second Header Logo

Christina Cramer

Concepts (100)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brain Neoplasms
21
2020
636
3.080
Why?
Radiosurgery
15
2020
355
1.930
Why?
Cranial Irradiation
7
2020
94
0.650
Why?
Radiotherapy
1
2019
92
0.560
Why?
Hypoglycemic Agents
1
2018
186
0.510
Why?
Salvage Therapy
5
2020
135
0.460
Why?
Retrospective Studies
17
2020
3612
0.460
Why?
Urinary Bladder Neoplasms
1
2018
189
0.460
Why?
Middle Aged
24
2020
11843
0.450
Why?
Aged
19
2020
10257
0.410
Why?
Treatment Outcome
11
2020
3410
0.410
Why?
Neoplasm Recurrence, Local
6
2020
372
0.390
Why?
Aged, 80 and over
10
2020
3896
0.360
Why?
Female
24
2020
19954
0.350
Why?
Male
22
2020
19434
0.340
Why?
Neuropsychological Tests
3
2019
327
0.330
Why?
Prognosis
9
2020
1529
0.310
Why?
Humans
26
2020
32284
0.310
Why?
Olfaction Disorders
1
2009
7
0.300
Why?
Affective Symptoms
1
2009
15
0.300
Why?
Neoplasms
4
2020
763
0.290
Why?
Meningioma
2
2020
59
0.280
Why?
Adult
13
2020
9263
0.280
Why?
Parkinson Disease
1
2009
87
0.280
Why?
Radiotherapy, Conformal
2
2018
18
0.270
Why?
Follow-Up Studies
5
2020
2238
0.260
Why?
Survival Rate
5
2020
892
0.230
Why?
Lung Neoplasms
3
2019
422
0.230
Why?
Melanoma
3
2019
166
0.180
Why?
Neoplasm Metastasis
2
2019
222
0.160
Why?
Breast Neoplasms
3
2017
767
0.160
Why?
Lymphatic Metastasis
2
2018
169
0.160
Why?
Radiotherapy, Adjuvant
2
2017
83
0.160
Why?
Carcinoma
1
2020
92
0.150
Why?
Trigeminal Neuralgia
1
2019
33
0.150
Why?
Small Cell Lung Carcinoma
1
2019
17
0.150
Why?
Disease Susceptibility
1
2019
61
0.140
Why?
Prospective Studies
3
2019
2320
0.140
Why?
Maximum Tolerated Dose
1
2018
62
0.140
Why?
Multiple Sclerosis
1
2019
61
0.140
Why?
Costs and Cost Analysis
1
2018
106
0.140
Why?
Genomics
1
2018
89
0.130
Why?
Hormones
1
2017
24
0.130
Why?
Receptors, Progesterone
1
2017
50
0.130
Why?
Meningeal Neoplasms
1
2017
49
0.130
Why?
Receptors, Estrogen
1
2017
104
0.130
Why?
Receptor, erbB-2
1
2017
63
0.130
Why?
Survivors
1
2018
174
0.130
Why?
Medicare
1
2018
218
0.130
Why?
Glioblastoma
1
2018
158
0.120
Why?
Quality of Life
2
2019
971
0.120
Why?
Cognition Disorders
1
2019
349
0.120
Why?
Hippocampus
1
2017
216
0.120
Why?
Retroperitoneal Neoplasms
1
2015
19
0.110
Why?
Young Adult
2
2020
2652
0.110
Why?
Sarcoma
1
2015
82
0.110
Why?
Adenocarcinoma
1
2017
298
0.110
Why?
Disease-Free Survival
3
2020
322
0.100
Why?
Smoking
1
2017
505
0.100
Why?
Disease Progression
3
2019
590
0.090
Why?
Neoplasm, Residual
1
2012
22
0.090
Why?
Radiation Dosage
2
2020
90
0.080
Why?
Psychiatric Status Rating Scales
1
2009
83
0.070
Why?
Smell
1
2009
45
0.070
Why?
Survival Analysis
2
2020
478
0.070
Why?
Incidence
2
2020
1244
0.060
Why?
Risk
2
2020
305
0.060
Why?
Combined Modality Therapy
2
2018
550
0.060
Why?
Risk Factors
2
2019
3938
0.040
Why?
Treatment Failure
1
2020
164
0.040
Why?
Radiotherapy Dosage
1
2019
106
0.040
Why?
Fatigue
1
2019
80
0.040
Why?
Databases, Factual
1
2020
368
0.040
Why?
Postoperative Period
1
2018
95
0.030
Why?
Disease Management
1
2019
129
0.030
Why?
Rats, Wistar
1
2017
111
0.030
Why?
Radiotherapy Planning, Computer-Assisted
1
2017
34
0.030
Why?
Radiometry
1
2017
52
0.030
Why?
Clinical Trials as Topic
1
2019
312
0.030
Why?
Brain Death
1
2017
23
0.030
Why?
Confidence Intervals
1
2017
141
0.030
Why?
Child, Preschool
1
2020
1248
0.030
Why?
Analysis of Variance
1
2017
470
0.030
Why?
Carcinoma, Renal Cell
1
2017
113
0.030
Why?
Cognition
1
2019
548
0.030
Why?
Cohort Studies
1
2019
1840
0.030
Why?
Perioperative Care
1
2015
51
0.030
Why?
Kidney Neoplasms
1
2017
200
0.030
Why?
Child
1
2020
2446
0.030
Why?
Rats
1
2017
1892
0.020
Why?
Brain
1
2019
966
0.020
Why?
Adolescent
1
2020
3521
0.020
Why?
Aminopyrine
1
2012
1
0.020
Why?
Phenylbutazone
1
2012
1
0.020
Why?
Mastectomy, Segmental
1
2012
25
0.020
Why?
Time Factors
1
2017
2196
0.020
Why?
Drug Combinations
1
2012
102
0.020
Why?
Neoplasm Invasiveness
1
2012
180
0.020
Why?
United States
1
2018
4079
0.020
Why?
Animals
1
2017
8165
0.010
Why?
Cramer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (100)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_